調査レポート | • レポートコード：QYR2104Z4021 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ナルコレプシー治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（中枢神経刺激薬、オキシベートナトリウム、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、その他）、用途別市場規模（脱力発作を伴うナルコレプシー、脱力発作を伴わないナルコレプシー、二次ナルコレプシー）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ナルコレプシー治療薬の市場動向 ・企業の競争状況、市場シェア ・ナルコレプシー治療薬の種類別市場規模（中枢神経刺激薬、オキシベートナトリウム、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、その他） ・ナルコレプシー治療薬の用途別市場規模（脱力発作を伴うナルコレプシー、脱力発作を伴わないナルコレプシー、二次ナルコレプシー） ・ナルコレプシー治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ナルコレプシー治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ナルコレプシー治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ナルコレプシー治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ナルコレプシー治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Addrenex Pharmaceuticals, Inc.、Teva Pharmaceutical Industries Ltd.、Jazz Pharmaceuticals PLC、Graymark Healthcare, Inc.、Arena Pharmaceuticals, Inc.、BIOPROJET、Takeda、Ligand Pharmaceuticals, Inc.） ・結論 |
Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. … These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time.
Market Analysis and Insights: Global Narcolepsy Therapeutics Market
The global Narcolepsy Therapeutics market size is projected to reach US$ 2020.3 million by 2026, from US$ 1184.2 million in 2019, at a CAGR of 7.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Narcolepsy Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Narcolepsy Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Narcolepsy Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Narcolepsy Therapeutics market.
Global Narcolepsy Therapeutics Scope and Market Size
Narcolepsy Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Narcolepsy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others
Segment by Application
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Takeda
Ligand Pharmaceuticals, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Central nervous system stimulants
1.2.3 Sodium Oxybate
1.2.4 Selective Serotonin Reuptake Inhibitor (SSRI)
1.2.5 Tricyclic Antidepressants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Narcolepsy Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Narcolepsy With Cataplexy
1.3.3 Narcolepsy Without Cataplexy
1.3.4 Secondary Narcolepsy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Therapeutics Market Perspective (2016-2027)
2.2 Narcolepsy Therapeutics Growth Trends by Regions
2.2.1 Narcolepsy Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Narcolepsy Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Narcolepsy Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Narcolepsy Therapeutics Industry Dynamic
2.3.1 Narcolepsy Therapeutics Market Trends
2.3.2 Narcolepsy Therapeutics Market Drivers
2.3.3 Narcolepsy Therapeutics Market Challenges
2.3.4 Narcolepsy Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Therapeutics Players by Revenue
3.1.1 Global Top Narcolepsy Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Narcolepsy Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Narcolepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Narcolepsy Therapeutics Revenue
3.4 Global Narcolepsy Therapeutics Market Concentration Ratio
3.4.1 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Therapeutics Revenue in 2020
3.5 Narcolepsy Therapeutics Key Players Head office and Area Served
3.6 Key Players Narcolepsy Therapeutics Product Solution and Service
3.7 Date of Enter into Narcolepsy Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcolepsy Therapeutics Breakdown Data by Type
4.1 Global Narcolepsy Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Narcolepsy Therapeutics Forecasted Market Size by Type (2022-2027)
5 Narcolepsy Therapeutics Breakdown Data by Application
5.1 Global Narcolepsy Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Narcolepsy Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Narcolepsy Therapeutics Market Size (2016-2027)
6.2 North America Narcolepsy Therapeutics Market Size by Type
6.2.1 North America Narcolepsy Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Narcolepsy Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Narcolepsy Therapeutics Market Size by Type (2016-2027)
6.3 North America Narcolepsy Therapeutics Market Size by Application
6.3.1 North America Narcolepsy Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Narcolepsy Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Narcolepsy Therapeutics Market Size by Application (2016-2027)
6.4 North America Narcolepsy Therapeutics Market Size by Country
6.4.1 North America Narcolepsy Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Narcolepsy Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Narcolepsy Therapeutics Market Size (2016-2027)
7.2 Europe Narcolepsy Therapeutics Market Size by Type
7.2.1 Europe Narcolepsy Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Narcolepsy Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Narcolepsy Therapeutics Market Size by Type (2016-2027)
7.3 Europe Narcolepsy Therapeutics Market Size by Application
7.3.1 Europe Narcolepsy Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Narcolepsy Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Narcolepsy Therapeutics Market Size by Application (2016-2027)
7.4 Europe Narcolepsy Therapeutics Market Size by Country
7.4.1 Europe Narcolepsy Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Narcolepsy Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Type
8.2.1 Asia-Pacific Narcolepsy Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Narcolepsy Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Narcolepsy Therapeutics Market Size by Application
8.3.1 Asia-Pacific Narcolepsy Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Narcolepsy Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Narcolepsy Therapeutics Market Size by Region
8.4.1 Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Narcolepsy Therapeutics Market Size (2016-2027)
9.2 Latin America Narcolepsy Therapeutics Market Size by Type
9.2.1 Latin America Narcolepsy Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Narcolepsy Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Narcolepsy Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Narcolepsy Therapeutics Market Size by Application
9.3.1 Latin America Narcolepsy Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Narcolepsy Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Narcolepsy Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Narcolepsy Therapeutics Market Size by Country
9.4.1 Latin America Narcolepsy Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Narcolepsy Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Type
10.2.1 Middle East & Africa Narcolepsy Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Narcolepsy Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Narcolepsy Therapeutics Market Size by Application
10.3.1 Middle East & Africa Narcolepsy Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Narcolepsy Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Narcolepsy Therapeutics Market Size by Country
10.4.1 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Addrenex Pharmaceuticals, Inc.
11.1.1 Addrenex Pharmaceuticals, Inc. Company Details
11.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
11.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2016-2021)
11.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Company Details
11.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Introduction
11.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2016-2021)
11.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.3 Jazz Pharmaceuticals PLC
11.3.1 Jazz Pharmaceuticals PLC Company Details
11.3.2 Jazz Pharmaceuticals PLC Business Overview
11.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Introduction
11.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2016-2021)
11.3.5 Jazz Pharmaceuticals PLC Recent Development
11.4 Graymark Healthcare, Inc.
11.4.1 Graymark Healthcare, Inc. Company Details
11.4.2 Graymark Healthcare, Inc. Business Overview
11.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Introduction
11.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2016-2021)
11.4.5 Graymark Healthcare, Inc. Recent Development
11.5 Arena Pharmaceuticals, Inc.
11.5.1 Arena Pharmaceuticals, Inc. Company Details
11.5.2 Arena Pharmaceuticals, Inc. Business Overview
11.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2016-2021)
11.5.5 Arena Pharmaceuticals, Inc. Recent Development
11.6 BIOPROJET
11.6.1 BIOPROJET Company Details
11.6.2 BIOPROJET Business Overview
11.6.3 BIOPROJET Narcolepsy Therapeutics Introduction
11.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2016-2021)
11.6.5 BIOPROJET Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Narcolepsy Therapeutics Introduction
11.7.4 Takeda Revenue in Narcolepsy Therapeutics Business (2016-2021)
11.7.5 Takeda Recent Development
11.8 Ligand Pharmaceuticals, Inc.
11.8.1 Ligand Pharmaceuticals, Inc. Company Details
11.8.2 Ligand Pharmaceuticals, Inc. Business Overview
11.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2016-2021)
11.8.5 Ligand Pharmaceuticals, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Narcolepsy Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Central nervous system stimulants
Table 3. Key Players of Sodium Oxybate
Table 4. Key Players of Selective Serotonin Reuptake Inhibitor (SSRI)
Table 5. Key Players of Tricyclic Antidepressants
Table 6. Key Players of Others
Table 7. Global Narcolepsy Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Narcolepsy Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Narcolepsy Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Narcolepsy Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Narcolepsy Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Narcolepsy Therapeutics Market Share by Regions (2022-2027)
Table 13. Narcolepsy Therapeutics Market Trends
Table 14. Narcolepsy Therapeutics Market Drivers
Table 15. Narcolepsy Therapeutics Market Challenges
Table 16. Narcolepsy Therapeutics Market Restraints
Table 17. Global Narcolepsy Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Narcolepsy Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Therapeutics as of 2020)
Table 20. Ranking of Global Top Narcolepsy Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Narcolepsy Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Narcolepsy Therapeutics Product Solution and Service
Table 24. Date of Enter into Narcolepsy Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Narcolepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Narcolepsy Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Narcolepsy Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Narcolepsy Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Narcolepsy Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Narcolepsy Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Narcolepsy Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Narcolepsy Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Narcolepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Narcolepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Narcolepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Narcolepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Narcolepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Narcolepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Narcolepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Narcolepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Narcolepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Narcolepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Narcolepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Narcolepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Narcolepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Narcolepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Narcolepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Narcolepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Narcolepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Narcolepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Narcolepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Narcolepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Narcolepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Narcolepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Narcolepsy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Narcolepsy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Narcolepsy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Narcolepsy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Addrenex Pharmaceuticals, Inc. Company Details
Table 65. Addrenex Pharmaceuticals, Inc. Business Overview
Table 66. Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
Table 67. Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Addrenex Pharmaceuticals, Inc. Recent Development
Table 69. Teva Pharmaceutical Industries Ltd. Company Details
Table 70. Teva Pharmaceutical Industries Ltd. Business Overview
Table 71. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Product
Table 72. Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Teva Pharmaceutical Industries Ltd. Recent Development
Table 74. Jazz Pharmaceuticals PLC Company Details
Table 75. Jazz Pharmaceuticals PLC Business Overview
Table 76. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Product
Table 77. Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Jazz Pharmaceuticals PLC Recent Development
Table 79. Graymark Healthcare, Inc. Company Details
Table 80. Graymark Healthcare, Inc. Business Overview
Table 81. Graymark Healthcare, Inc. Narcolepsy Therapeutics Product
Table 82. Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Graymark Healthcare, Inc. Recent Development
Table 84. Arena Pharmaceuticals, Inc. Company Details
Table 85. Arena Pharmaceuticals, Inc. Business Overview
Table 86. Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
Table 87. Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Arena Pharmaceuticals, Inc. Recent Development
Table 89. BIOPROJET Company Details
Table 90. BIOPROJET Business Overview
Table 91. BIOPROJET Narcolepsy Therapeutics Product
Table 92. BIOPROJET Revenue in Narcolepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 93. BIOPROJET Recent Development
Table 94. Takeda Company Details
Table 95. Takeda Business Overview
Table 96. Takeda Narcolepsy Therapeutics Product
Table 97. Takeda Revenue in Narcolepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Takeda Recent Development
Table 99. Ligand Pharmaceuticals, Inc. Company Details
Table 100. Ligand Pharmaceuticals, Inc. Business Overview
Table 101. Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Ligand Pharmaceuticals, Inc. Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcolepsy Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Central nervous system stimulants Features
Figure 3. Sodium Oxybate Features
Figure 4. Selective Serotonin Reuptake Inhibitor (SSRI) Features
Figure 5. Tricyclic Antidepressants Features
Figure 6. Others Features
Figure 7. Global Narcolepsy Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Narcolepsy With Cataplexy Case Studies
Figure 9. Narcolepsy Without Cataplexy Case Studies
Figure 10. Secondary Narcolepsy Case Studies
Figure 11. Narcolepsy Therapeutics Report Years Considered
Figure 12. Global Narcolepsy Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Narcolepsy Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Narcolepsy Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Narcolepsy Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Narcolepsy Therapeutics Market Share by Players in 2020
Figure 17. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Narcolepsy Therapeutics Revenue in 2020
Figure 19. Global Narcolepsy Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Narcolepsy Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Narcolepsy Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Narcolepsy Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Narcolepsy Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Narcolepsy Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Narcolepsy Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Narcolepsy Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Narcolepsy Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Narcolepsy Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Narcolepsy Therapeutics Market Share by Region (2016-2027)
Figure 41. China Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Narcolepsy Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Narcolepsy Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Narcolepsy Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Narcolepsy Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Narcolepsy Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Narcolepsy Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Narcolepsy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Addrenex Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2016-2021)
Figure 61. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Narcolepsy Therapeutics Business (2016-2021)
Figure 62. Jazz Pharmaceuticals PLC Revenue Growth Rate in Narcolepsy Therapeutics Business (2016-2021)
Figure 63. Graymark Healthcare, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2016-2021)
Figure 64. Arena Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2016-2021)
Figure 65. BIOPROJET Revenue Growth Rate in Narcolepsy Therapeutics Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in Narcolepsy Therapeutics Business (2016-2021)
Figure 67. Ligand Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のナルコレプシー治療市場規模・現状・予測（2021年-2027年） Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep. By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimu…- 世界のナルコレプシー市場規模・現状・予測（2021年-2027年） Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at …
- 世界の中枢神経系（CNS）障害治療市場規模・現状・予測（2021年-2027年） Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Depression is the dominated market of CNS Disorders Therapeutics Market Analysis and Insights: Global Central Nervous System Disorders …
- 世界の産後うつ病治療薬市場規模・現状・予測（2021年-2027年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 世界の双極性障害治療市場規模・現状・予測（2021年-2027年） Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. Market Analysis and Insights: Global Bipolar…